313 related articles for article (PubMed ID: 33638018)
1. Stroke and presence of patent foramen ovale in sickle cell disease.
Aggeli C; Polytarchou K; Dimitroglou Y; Patsourakos D; Delicou S; Vassilopoulou S; Tsiamis E; Tsioufis K
J Thromb Thrombolysis; 2021 Oct; 52(3):889-897. PubMed ID: 33638018
[TBL] [Abstract][Full Text] [Related]
2. The Case for Selective Patent Foramen Ovale Closure After Cryptogenic Stroke.
Wiktor DM; Carroll JD
Circ Cardiovasc Interv; 2018 Mar; 11(3):e004152. PubMed ID: 29870380
[TBL] [Abstract][Full Text] [Related]
3. Transcatheter Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke: A Meta-Analysis of Randomized Controlled Trials.
Darmoch F; Al-Khadra Y; Soud M; Fanari Z; Alraies MC
Cerebrovasc Dis; 2018; 45(3-4):162-169. PubMed ID: 29597192
[TBL] [Abstract][Full Text] [Related]
4. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
[TBL] [Abstract][Full Text] [Related]
5. Patent Foramen Ovale and Cryptogenic Stroke or Transient Ischemic Attack: To Close or Not to Close? A Systematic Review and Meta-Analysis.
Lattanzi S; Brigo F; Cagnetti C; Di Napoli M; Silvestrini M
Cerebrovasc Dis; 2018; 45(5-6):193-203. PubMed ID: 29649819
[TBL] [Abstract][Full Text] [Related]
6. Patent foramen ovale (PFO) closure versus medical therapy for prevention of recurrent stroke in patients with prior cryptogenic stroke: A systematic review and meta-analysis of randomized controlled trials.
Akobeng AK; Abdelgadir I; Boudjemline Y; Hijazi ZM
Catheter Cardiovasc Interv; 2018 Jul; 92(1):165-173. PubMed ID: 29602258
[TBL] [Abstract][Full Text] [Related]
7. Patent foramen ovale and cryptogenic stroke.
Nakanishi K; Yoshiyama M; Homma S
Trends Cardiovasc Med; 2017 Nov; 27(8):575-581. PubMed ID: 28709812
[TBL] [Abstract][Full Text] [Related]
8. Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke.
Mas JL; Derumeaux G; Guillon B; Massardier E; Hosseini H; Mechtouff L; Arquizan C; Béjot Y; Vuillier F; Detante O; Guidoux C; Canaple S; Vaduva C; Dequatre-Ponchelle N; Sibon I; Garnier P; Ferrier A; Timsit S; Robinet-Borgomano E; Sablot D; Lacour JC; Zuber M; Favrole P; Pinel JF; Apoil M; Reiner P; Lefebvre C; Guérin P; Piot C; Rossi R; Dubois-Randé JL; Eicher JC; Meneveau N; Lusson JR; Bertrand B; Schleich JM; Godart F; Thambo JB; Leborgne L; Michel P; Pierard L; Turc G; Barthelet M; Charles-Nelson A; Weimar C; Moulin T; Juliard JM; Chatellier G;
N Engl J Med; 2017 Sep; 377(11):1011-1021. PubMed ID: 28902593
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of intracardiac shunting in children with sickle cell disease and stroke.
Dowling MM; Lee N; Quinn CT; Rogers ZR; Boger D; Ahmad N; Ramaciotti C; Buchanan GR
J Pediatr; 2010 Apr; 156(4):645-50. PubMed ID: 20022343
[TBL] [Abstract][Full Text] [Related]
10. Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study.
Paciaroni M; Agnelli G; Bertolini A; Pezzini A; Padovani A; Caso V; Venti M; Alberti A; Palmiero RA; Cerrato P; Silvestrelli G; Lanari A; Previdi P; Corea F; Balducci A; Ferri R; Falcinelli F; Filippucci E; Chiocchi P; Grandi FC; Ferigo L; Musolino R; Bersano A; Ghione I; Sacco S; Carolei A; Baldi A; Ageno W;
Cerebrovasc Dis; 2011; 31(2):109-16. PubMed ID: 21088390
[TBL] [Abstract][Full Text] [Related]
11. Transcatheter closure of patent foramen ovale to prevent stroke recurrence in patients with otherwise unexplained ischaemic stroke: Expert consensus of the French Neurovascular Society and the French Society of Cardiology.
Mas JL; Derex L; Guérin P; Guillon B; Habib G; Juliard JM; Marijon E; Massardier E; Meneveau N; Vuillier F
Arch Cardiovasc Dis; 2019; 112(8-9):532-542. PubMed ID: 31378692
[TBL] [Abstract][Full Text] [Related]
12. Patent Foramen Ovale: A Comprehensive Review.
Teshome MK; Najib K; Nwagbara CC; Akinseye OA; Ibebuogu UN
Curr Probl Cardiol; 2020 Feb; 45(2):100392. PubMed ID: 30327131
[No Abstract] [Full Text] [Related]
13. Closure, Anticoagulation, or Antiplatelet Therapy for Cryptogenic Stroke With Patent Foramen Ovale: Systematic Review of Randomized Trials, Sequential Meta-Analysis, and New Insights From the CLOSE Study.
Turc G; Calvet D; Guérin P; Sroussi M; Chatellier G; Mas JL;
J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29910193
[TBL] [Abstract][Full Text] [Related]
14. Dilemma in approach to stroke in sickle cell disease patient: A case report.
Okar L; Ali Alzoubi H; Shukur Mahmud S; Elyas A; Yassin MA
Medicine (Baltimore); 2022 Jul; 101(28):e29131. PubMed ID: 35839057
[TBL] [Abstract][Full Text] [Related]
15. Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis.
Khan AR; Bin Abdulhak AA; Sheikh MA; Khan S; Erwin PJ; Tleyjeh I; Khuder S; Eltahawy EA
JACC Cardiovasc Interv; 2013 Dec; 6(12):1316-23. PubMed ID: 24139929
[TBL] [Abstract][Full Text] [Related]
16. Recurrent events after percutaneous closure of patent foramen ovale.
Wallenborn J; Bertog SC; Franke J; Steinberg DH; Majunke N; Wilson N; Wunderlich N; Sievert H
Catheter Cardiovasc Interv; 2013 Oct; 82(4):541-6. PubMed ID: 22707325
[TBL] [Abstract][Full Text] [Related]
17. Patent foramen ovale closure for secondary stroke prevention.
Alkhouli M; Sievert H; Holmes DR
Eur Heart J; 2019 Jul; 40(28):2339-2350. PubMed ID: 30957864
[TBL] [Abstract][Full Text] [Related]
18. Updated meta-analysis of closure of patent foramen ovale versus medical therapy after cryptogenic stroke.
Nasir UB; Qureshi WT; Jogu H; Wolfe E; Dutta A; Majeed CN; Tan WA
Cardiovasc Revasc Med; 2019 Mar; 20(3):187-193. PubMed ID: 30905408
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes of patent foramen ovale closure or medical therapy after cryptogenic stroke: A meta-analysis of randomized trials.
Abdelaziz HK; Saad M; Abuomara HZ; Nairooz R; Pothineni NVK; Madmani ME; Roberts DH; Mahmud E
Catheter Cardiovasc Interv; 2018 Jul; 92(1):176-186. PubMed ID: 29726616
[TBL] [Abstract][Full Text] [Related]
20. Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke.
Søndergaard L; Kasner SE; Rhodes JF; Andersen G; Iversen HK; Nielsen-Kudsk JE; Settergren M; Sjöstrand C; Roine RO; Hildick-Smith D; Spence JD; Thomassen L;
N Engl J Med; 2017 Sep; 377(11):1033-1042. PubMed ID: 28902580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]